The lack of evidence emerges from prospective human studies that have been aimed at understanding the mechanism between the beginning component of the lectin pathway, i.e., mannose-binding lectin (MBL), and endothelial dysfunction, low-grade inflammation, or carotid intima-media thickness. This evidence concerns the gene MBL2 and endothelial dysfunction.